Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | PGK1 | P00558 | 1/20 | 0.37 |
| ▸ | PGK2 | P07205 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | IDH1 | O75874 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.32 |
| ▸ | TPMT | P51580 | 1/20 | 0.32 |
| ▸ | TACR1 | P25103 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.31 |
| ▸ | C1S | P09871 | 1/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4160774 | 0.97 | ALDH1A1 (0.38) | ALDH1A1TSHRPGK1PGK2TRPA1 | |
| SCHEMBL2261460 | 0.94 | PGK1 (0.42) | ALDH1A1TSHRPGK1PGK2TRPA1 | |
| SCHEMBL305652 | 0.84 | TACR1 (0.41) | ALDH1A1TSHRPGK1PGK2TRPA1 | |
| SCHEMBL30349373 | 0.84 | TACR1 (0.41) | ALDH1A1TSHRPGK1PGK2TRPA1 | |
| SCHEMBL334160 | 0.82 | NR1D1 (0.35) | TSHRPGK1PGK2 | |
| SCHEMBL11345442 | 0.82 | ALDH1A1 (0.55) | ALDH1A1PGK1PGK2IDH1ACHE | |
| SCHEMBL642656 | 0.82 | TACR1 (0.31) | PGK1PGK2TACR1 | |
| SCHEMBL2924850 | 0.82 | ACHE (0.36) | PGK1PGK2IDH1ACHE | |
| SCHEMBL13498488 | 0.78 | PARP10 (0.46) | MAOA | |
| SCHEMBL9616495 | 0.78 | IDO1 (0.38) | ALDH1A1TSHRTRPA1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 665 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12304917-B1 | Pleuromutilin derivative containing a thiazolo[5,4-c]pyridine side chain, and a preparation method and application thereof | SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-05-20 | — | — | US | claimed |
| US-12275734-B1 | Pleuromutilin onium salt derivative containing a 3H-imidazo[4,5-c]pyridine side chain, and a preparation method and application thereof | SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-04-15 | — | — | US | claimed |
| CN-119686030-A | Superfine fiber oil-water emulsion separation membrane and preparation method and application thereof | 嘉兴富瑞邦新材料科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-118546138-A | 3H-imidazo [4,5-C ] pyridine pleuromutilin onium salt derivatives, and preparation method and application thereof | 西安康诺化工有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-118546155-A | Pleuromutilin derivative containing thiazolo [5,4-C ] pyridine side chain and preparation method and application thereof | 西安康诺化工有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-113444079-B | Rotaxane molecular machine based on crown ether and preparation method | 浙江工业大学 | 2022-07-01 | — | — | CN | claimed |
| CN-112473396-B | Anion exchange membrane material for diffusion dialysis acid recovery and preparation method thereof | 西安建筑科技大学 | 2022-06-24 | — | — | CN | claimed |
| CN-114149421-A | Palmatine derivative, preparation method and antithrombotic application thereof | 中国医学科学院医药生物技术研究所 | 2022-03-08 | — | — | CN | claimed |
| CN-112473396-A | Anion exchange membrane material for diffusion dialysis acid recovery and preparation method thereof | 西安建筑科技大学 | 2021-03-12 | — | — | CN | claimed |
| CN-106866557-B | (Z)-β-alkenyl bromine multicomponent prepares the method and application of 1,4- substitution -1,2,3- triazole | 乐山师范学院 | 2019-11-12 | — | — | CN | claimed |
| US-20130184484-A1 | PROCESS FOR PREPARING BORONIC ACIDS AND ESTERS IN THE PRESENCE OF MAGNESIUM METAL | UNIVERSITE DE NICE SOPHIA ANTIPOLIS (FR) | 2013-07-18 | — | — | US | claimed |
| US-20110282090-A1 | PROCESS FOR PREPARING BORONIC ACIDS AND ESTERS IN THE PRESENCE OF MAGNESIUM METAL | UNIVERSITE DE NICE SOPHIA ANTIPOLIS (FR) | 2011-11-17 | — | — | US | claimed |
| CN-122013209-A | Hydroxy substituted alkane compound and method for synthesizing hydroxy substituted alkane compound by electrochemical reduction coupling | 山东金科力电源科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4683919-A1 | VANIN-1 INHIBITORS | Athos Therapeutics, Inc. (US) | 2026-01-28 | — | — | EP | disclosed |
| EP-4646410-A1 | TUBULIN POLYMERIZATION INHIBITORS | AB Science (FR) | 2025-11-12 | — | — | EP | disclosed |
| EP-3630779-B1 | ANTIBIOTIC RESISTANCE BREAKERS | KING S COLLEGE LONDON (GB) | 2025-09-03 | — | — | EP | disclosed |
| EP-0296749-A1 | (Substituted aralkyl) heterocyclic compounds | ZENECA LIMITED (GB) | 1988-12-28 | — | — | EP | disclosed |
| US-4639267-A | Herbicidal cyclohexane-1,3-dione derivatives | ICI AUSTRALIA LIMITED (AU) | 1987-01-27 | — | — | US | disclosed |
| EP-0176294-A1 | Cyclohexane-1,3-dione derivatives, compositions containing them, processes for preparing them, and their use as herbicides and plant growth regulators | ICI AUSTRALIA LIMITED (AU) | 1986-04-02 | — | — | EP | disclosed |
| US-4046656-A | Photochlorination process for methyl aromatic compounds | THE DOW CHEMICAL COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12275734-B1 | Pleuromutilin onium salt derivative containing a 3H-imidazo[4,5-c]pyridine side chain, and a preparation method and application thereof | PLEC, PML, MRPL21 | ALDH1A1 2527/4885TSHR 1783/4885PGK1 3800/4885 |
| US-20110282090-A1 | PROCESS FOR PREPARING BORONIC ACIDS AND ESTERS IN THE PRESENCE OF MAGNESIUM METAL | ME1, MEN1, CYP2B6 | ALDH1A1 3043/4885TSHR 1734/4885PGK1 2057/4885 |
| US-12304917-B1 | Pleuromutilin derivative containing a thiazolo[5,4-c]pyridine side chain, and a preparation method and application thereof | PLEC, MLN, MRPL21 | ALDH1A1 1092/4885TSHR 539/4885PGK1 3938/4885 |
| US-20130184484-A1 | PROCESS FOR PREPARING BORONIC ACIDS AND ESTERS IN THE PRESENCE OF MAGNESIUM METAL | ME1, MEN1, CYP2B6 | ALDH1A1 3043/4885TSHR 1734/4885PGK1 2057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.